Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Piperidine | HCID 8082 | — |
| Reactant | 6-Formyl-4-isopropoxy-[1,5]naphthyridine-3-carbonitrile | HCID 58724311 | — |
| Reactant | benzyl 5-oxo-2-[[2-(trifluoromethyl)phenyl]methylamino]-4H-imidazole-3-carboxylate | HCID 178516790 | — |
| Solvent | Isopropanol | HCID 3776 | — |
| Product | HCID 178458705 | HCID 178458705 | — |
Reaction Steps
To a mixture of 4-oxo-2-(2-trifluoromethyl-benzylamino)-4,5-dihydro-imidazole-1-carboxylic acid benzyl ester (70.4 mg, 0.18 mmol) (prepared as described in C-H Kwon et al. J. Med. Chem. 1991, 34, 1845-1849), 6-formyl-4-isopropoxy-[1,5]naphthyridine-3-carbonitrile (56.5 mg, 0.23 mmol) (see Example 1) and iPrOH (5 mL) in a 25-mL round bottom flask was added piperidine (0.05 mL) and the suspension was then heated under refluxing for 5 h to give a brown solution. The reaction mixture was cooled to r.t. and concentrated to give a light yellow solid, 66.3 mg, which was purified by flash column purification to give 4-isopropoxy-6-[5-oxo-2-(2-trifluoromethyl-benzylamino)-3,5-dihydro-imidazol-4-ylidenemethyl]-[1,5]naphthyridine-3-carbonitrile, as a light yellow solid, 18.6 mg (21.5%). HR-ES (+) m/e calcd for C24H19F3N6O2 (M+H)+ 481.1595. found 481.1595.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07304074B2 |
|---|
| Source dataset | uspto-grants-2007_12 |
|---|
| ORD ID | ord-2e38aa8007b74776b5f628c35949af03 |
|---|
| Source note | uspto-grants-2007_12 |
|---|